Mammalian Polyclonal IgG Antibody Market Expands with Increasing Biopharmaceutical Research and Diagnostics Applications
The Mammalian Polyclonal IgG Antibody Market was valued at USD 1,155.92 million in 2022 and is projected to reach USD 1,980.10 million by 2032, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period. Increasing prevalence of chronic diseases, rising demand for diagnostic testing, and growth in biopharmaceutical research and...
0 Комментарии 0 Поделились 31 Просмотры 0 предпросмотр